Australia

US based COBRA diagnostic prostate cancer trial reaches recruitment target

SYDNEY, Feb. 9, 2023 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for children and adults with cancer, is pleased to announce its diagnostic 64Cu SAR-...

2023-02-09 22:03 3224

6clicks Adds GPT-3 to Accelerate Risk Management, Automate Compliance Mapping and Advance Accuracy

Complex Natural Language Comprehension from OpenAI Adds "Ask Hailey" Understanding of Language Nuances to Powerful 6clicks GRC AI Engine MELBOURNE, Australia, Feb. 8, 2023 /PRNewswire/ -- 6clicks , the GRC innovators, today announced "Ask Hailey," the next step in Gover...

2023-02-08 22:06 3140

Developers of PERC solar technology win 2023 Queen Elizabeth Prize for Engineering (QEPrize)

Professor Martin Green, Professor Andrew Blakers, Dr Aihua Wang and Dr Jianhua Zhao are awarded the world's most prestigious engineering accolade for transforming the efficiency of solar cells and dramatically reducing costs, making solar the cheapest source of electricity in most countries. LON...

2023-02-08 03:45 3332

Inmagene receives IND clearance for IMG-008, a long-acting IL-36R mAb

SAN DIEGO, SHANGHAI and SYDNEY, Feb. 6, 2023 /PRNewswire/ -- Inmagene Biopharmaceuticals ("Inmagene") announced that the U.S. Food and Drug Administration (FDA) recently granted the initial investigational new drug (IND) application for its drug candidate IMG-008, a long-acting anti-IL-36R antib...

2023-02-06 18:00 2929

Ground-breaking results in Phase 2 scleroderma study by Certa Therapeutics demonstrates improvement in more than 60% of patients

* Data from Certa Therapeutics' Phase 2 clinical trial with development candidate FT011 demonstratesclinically meaningful improvements for more than 60 percent of patients with scleroderma after 12 weeks of treatment; * Clinically meaningful improvements were reported in CRISS (the key compos...

2023-02-06 13:01 2727

Jackery Enters Australian Market to Power a Greener Future

The leading solar generator company is now serving Aussie consumers, bringing more green power solutions to those living down under FREMONT, Calif. , Feb. 1, 2023 /PRNewswire/ -- Jackery , the global leader in providing portable power stations and solar panels, striv...

2023-02-01 19:22 3005

AI Coach creator Fingerprint for Success (F4S) raises AU$5 Million

* $5M seed round led by Investible; $9M in total funding raised to date * Investment to further accelerate product development in Generative AI Coach 'Marlee', the powerful behavioral change app embraced by Canva, Atlassian, KPMG and Baraja * New third party integrations to offer a 'Grammarl...

2023-02-01 05:00 3991

Appendix 4C - Q2 FY23 Quarterly Cash Flow Report

Highlights: * Expanded participation in ATH434 Phase 2 clinical trial with sites opened for recruitment inAustralia, the United States, and Italy * Presented compelling bioMUSE data at two prestigious industry conferences * Granted a 20-year patent for 100 new compounds targeting Parkinson's...

2023-01-31 20:25 5257

Minviro completes successful capital raise of £2,100,000 and welcomes industry leading investors as new shareholders

Funds raised will be dedicated to helping Minviro expand into key markets, includingAsia, Australia and the Americas, and develop local operational presence to serve a rapidly growing global client base. LONDON, Jan. 26, 2023 /PRNewswire/ -- Minviro is a market leading sustainability consulting ...

2023-01-26 18:00 3128

Whispir announces a partnership with a leading flexible and integrated payment and engagement platform, Everyware®

MELBOURNE, Australia, Jan. 18, 2023 /PRNewswire/ -- Whispir Limited (ASX:WSP, Whispir or Company), a global communications intelligence company that supplies a no code, Communications-as-a-Service ("CaaS") platform, today announced its partnership with Everyware® to provide secure, reliable Pay b...

2023-01-18 21:53 4385

SEA Electric Partners with MEVCO to Electrify 8,500 Hilux and Landcruiser Models for Mining Industry

MELBOURNE, Austalia, Jan. 17, 2023 /PRNewswire/ -- SEA Electric has made the next step in its journey to electrify the world's commercial vehicle fleet, by signing a significant Memorandum of Understanding with MEVCO, a leading systems integrator focused exclusively on electric light commercial v...

2023-01-18 06:36 2632

Really Simple Systems Announces Collaboration Project with Rareloop

Global CRM software provider, Really Simple Systems, has announced a joint project with software development agency, Rareloop, to build a mobile app PETERSFIELD, England, Jan. 17, 2023 /PRNewswire/ -- Leading cloud software vendor,Really Simple Systems

2023-01-17 18:00 3122

Denave unveils new visual identity

The new look reflects the company's dynamic approach and reaffirms commitment to growth NEW DELHI, Jan. 12, 2023 /PRNewswire/ -- Denave, a global technology-powered sales enablement enterprise, today announced a brand refresh including a new visual identity, redesigned logo and website, as part ...

2023-01-12 15:30 2851

Alterity Therapeutics Launches ATH434 Phase 2 Clinical Trial in the United States for the Treatment of Individuals with Multiple System Atrophy

U.S. now open for enrollment of rare, rapidly progressive Parkinsonian Disorder MELBOURNE, Australia and SAN FRANCISCO, Jan. 9, 2023 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying tre...

2023-01-09 23:25 3568

Alterity Therapeutics Announces 1-for-10 Reverse ADS Split (consolidation)

MELBOURNE, Australia and SAN FRANCISCO, Jan. 6, 2023 /PRNewswire/ -- Alterity Therapeutics Limited ("Alterity" or the "Company") (ASX:ATH, NASDAQ:ATHE), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced that its Board of D...

2023-01-06 20:25 4955

Alterity Therapeutics to Participate in the Sachs Associates 6th Annual Neuroscience Innovation Forum

MELBOURNE, Australia and SAN FRANCISCO, Jan. 3, 2023 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced thatDavid Stamler, M.D., ...

2023-01-03 23:25 2672

Alterity Therapeutics Announces Allowance of New Composition of Matter Patent by the United States Patent and Trademark Office

- Patent covers more than 100 novel compounds targeting neurodegenerative diseases including Parkinson's and Alzheimer's - MELBOURNE, Australia and SAN FRANCISCO, Dec. 29, 2022 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company d...

2022-12-29 23:25 3645

FDA agrees to Actinogen six-month Phase 2b Alzheimer's Disease trial

Exploring Xanamem® and the "cortisol hypothesis" for more than 6 million Americans suffering from Alzheimer's Disease[1]  SYDNEY, Dec. 22, 2022 /PRNewswire/ -- Actinogen Medical Limited (ASX: ACW) is pleased to announce receipt today of agreement from the US Food and Drug Administration (FDA) to...

2022-12-22 20:30 2876

Initial plan of development completed for Blue Star's world-class Las Animas helium project

PERTH, Australia, Dec. 19, 2022 /PRNewswire/ -- Blue Star Helium (ASX:BNL / OTCQB: BSNLF) (Blue Star or the Company) advises of the key outcomes from the Initial Plan of Development for its Las Animas Helium Project inColorado, USA. Highlights: Voyager – low capital intensity development of high...

2022-12-19 15:28 2874

Oracle Teams Up With OneQode to Deliver Low-Latency Solutions Across Asia-Pacific

SYDNEY, Dec. 15, 2022 /PRNewswire/ -- OneQode, Global Infrastructure-as-a-Service (IaaS) company, today announced it has joined Oracle PartnerNetwork (OPN). With OneQode now an OPN member, both companies will be able to provide enhanced offerings to enterprise customers in theAsia-Pacific region...

2022-12-15 22:00 3884
1 ... 19202122232425 ... 41